Effects of Mepivacaine on the Neurological Sequelae of Cerebral Infarction

Clinical trial NCT05222828 · UNKNOWN

Trial details

NCT number: NCT05222828
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ischemic Stroke

Start date: 2022-06-22
Primary completion: 2024-06-22
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.